Helicobacter Pylori Infection Clinical Trial
Official title:
The Effect of Citric Acid as the Test Meal on the Diagnostic Accuracy of the 13C-Urea Breath Test in Korean, Randomized Controlled, Open Label Prospective Study
1. To compare the diagnostic accuracy of the 13C-Urea breath test between using the citric
acid as test meal and controlled group by endoscopic biopsy methods(histology, CLOtest
and H. pylori culture).
2. To compare the delta value of 13CO2 results between before and after ingestion of citric
acid as test meal.
1-1 Screening (visit 1, From -6 to -8 weeks) and H. pylori eradication
1. To accept the agreement, confirm inclusion/exclusion criteria, and evaluate the baseline
characteristics of patients
2. H. pylori eradication
- First eradication: PPI-based triple therapy (standard dose of PPI b.i.d.,
clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d. for 1 week), and
sequential therapy (initial 5-day therapy with a combination of PPI b.i.d and
amoxicillin 1g b.i.d, followed by 5 days of PPI b.i.d., clarithromycin 500mg
b.i.d., and metronidazole 500mg t.i.d)
- Rescue therapy: bismuth-containing quadruple therapy [PPI b.i.d., tripotassium
dicitrate bismuthate 300 mg q.i.d. (three tablets at 30 min before meals and one
tablet at 2 hours after dinner), metronidazole 500 mg t.i.d., and tetracycline 500
mg q.i.d.] for 1-2 weeks, or moxifloxacin-containing triple therapy (moxifloxacin
400 mg q.d., amoxicillin 1g b.i.d., and PPI b.i.d.) for 1-2 weeks.
1-2 Baseline (visit 2, 0 week): urea breath test
1. Reconfirm inclusion and exclusion criteria
2. Randomization for UBT test (citric acid group vs control group)
3. In citric acid group: taking 4 g of citric acid solving in 200 ml of water 10 minutes
before UBT.
4. Perform UBT in both group
1-3) Endoscopic surveillance (visit 3, 6 or later months)
1. Endoscopic surveillance for final H. pylori status after UBT
- Histology, CLOtest or H. pylori culture
2. Statical analysis for diagnostic accuracy of the UBT between citric acid group and
controlled group: sensitivity, specificity, positive predictive value, negative
predictive value, false positive rate, and false negative rate.
2. Selecting 40 patients who showed UBT result between 2.5 to 4.0 in controlled group, the
investigators are planning to reperform 13C-UBT after giving citric acid as test meal.
And then, the investigators compare the change of UBT result before and after ingestion
citric acid as test meal.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05061732 -
Helicobacter Pylori Eradication and Follow-up
|
Phase 4 | |
Completed |
NCT03779074 -
Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies
|
Phase 3 | |
Completed |
NCT06076681 -
A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules
|
Phase 1/Phase 2 | |
Recruiting |
NCT05329636 -
Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
|
Phase 1/Phase 2 | |
Recruiting |
NCT05065138 -
Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists
|
N/A | |
Completed |
NCT05049902 -
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
|
Phase 4 | |
Not yet recruiting |
NCT06200779 -
Tailored vs. Empirical Helicobacter Pylori Infection Treatment
|
Phase 4 | |
Not yet recruiting |
NCT06037122 -
Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication
|
||
Completed |
NCT04617613 -
Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait
|
Phase 4 | |
Withdrawn |
NCT02552641 -
Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole
|
Phase 4 | |
Completed |
NCT02873247 -
Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori
|
||
Completed |
NCT02557932 -
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
|
Phase 3 | |
Recruiting |
NCT02249546 -
Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
|
Phase 4 | |
Completed |
NCT01933659 -
Anti-H. Pylori Effect of Deep See Water
|
Phase 3 | |
Unknown status |
NCT01464060 -
14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
|
Phase 4 | |
Completed |
NCT00841490 -
Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults
|
N/A | |
Recruiting |
NCT05549115 -
Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection
|
N/A | |
Recruiting |
NCT05728424 -
One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL
|
Phase 3 | |
Recruiting |
NCT05997433 -
Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori(SHARE2302)
|
N/A | |
Completed |
NCT04708405 -
The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life Observation
|